June 30, 2026 · Form 4 insider transaction
Simpson Curran bought 1,453 shares of REGENXBIO Inc. at $10.18 per share, a transaction worth $14.8K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 6 days after the transaction.
The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the ESPP for the ESPP purchase period of January 1, 2026 through June 30, 2026. This transaction is exempt under Rule 16b-3(c).; In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on June 30, 2026.